Opendata, web and dolomites

EnDeCAD SIGNED

Enhancers Decoding the Mechanisms Underlying CAD Risk

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 EnDeCAD project word cloud

Explore the words cloud of the EnDeCAD project. It provides you a very rough idea of what is the project "EnDeCAD" about.

provides    function    noncoding    candidate    cells    snps    establishment    events    data    link    variants    cardiovascular    hope    causal    array    biomarker    adipocytes    complete    enhancers    biological    hepatocytes    loci    deep    picture    treatment    combination    linking    metabolomics    discovered    parallel    functional    disease    mechanisms    cell    identification    physical    muscle    risk    regulatory    translatable    significantly    breakthrough    ultimately    single    association    heritability    characterization    strives    eqtl    genetic    massively    hundreds    expression    genes    collection    macrophages    discoveries    molecular    interaction    gwas    gene    portion    roles    date    search    driving    cad    explained    coronary    smooth    progression    artery    obtain    small    wall    majority    fundamental    lying    snp    understand    endothelial    clinical    nucleotide    vessel    polymorphisms    additionally    relationships    genome    regions    pioneering    prediction    correlative    stimuli    types    enhancer    trait    phenotypic    basis    vast    linked   

Project "EnDeCAD" data sheet

The following table provides information about the project.

Coordinator
ITA-SUOMEN YLIOPISTO 

Organization address
address: YLIOPISTONRANTA 1 E
city: KUOPIO
postcode: 70211
website: www.uef.fi

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Finland [FI]
 Total cost 1˙498˙647 €
 EC max contribution 1˙498˙647 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2018-STG
 Funding Scheme ERC-STG
 Starting year 2019
 Duration (year-month-day) from 2019-01-01   to  2023-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ITA-SUOMEN YLIOPISTO FI (KUOPIO) coordinator 1˙498˙647.00

Map

 Project objective

In recent years, genome-wide association studies (GWAS) have discovered hundreds of single nucleotide polymorphisms (SNPs) which are significantly associated with coronary artery disease (CAD). However, the SNPs identified by GWAS explain typically only small portion of the trait heritability and vast majority of variants do not have known biological roles. This is explained by variants lying within noncoding regions such as in cell type specific enhancers and additionally ‘the lead SNP’ identified in GWAS may not be the ‘the causal SNP’ but only linked with a trait associated SNP. Therefore, a major priority for understanding disease mechanisms is to understand at the molecular level the function of each CAD loci. In this study we aim to bring the functional characterization of SNPs associated with CAD risk to date by focusing our search for causal SNPs to enhancers of disease relevant cell types, namely endothelial cells, macrophages and smooth muscle cells of the vessel wall, hepatocytes and adipocytes. By combination of massively parallel enhancer activity measurements, collection of novel eQTL data throughout cell types under disease relevant stimuli, identification of the target genes in physical interaction with the candidate enhancers and establishment of correlative relationships between enhancer activity and gene expression we hope to identify causal enhancer variants and link them with target genes to obtain a more complete picture of the gene regulatory events driving disease progression and the genetic basis of CAD. Linking these findings with our deep phenotypic data for cardiovascular risk factors, gene expression and metabolomics has the potential to improve risk prediction, biomarker identification and treatment selection in clinical practice. Ultimately, this research strives for fundamental discoveries and breakthrough that advance our knowledge of CAD and provides pioneering steps towards taking the growing array of GWAS for translatable results.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ENDECAD" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ENDECAD" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

CHIPTRANSFORM (2018)

On-chip optical communication with transformation optics

Read More  

OAlipotherapy (2018)

Long-retention liposomic drug-delivery for intra-articular osteoarthritis therapy

Read More  

QUAMAP (2019)

Quasiconformal Methods in Analysis and Applications

Read More